Benjamin Toogood

Benjamin Toogood

Président chez KDVENTURES AB
50 ans
Health Technology
Consumer Services
Finance

Profil

Benjamin Toogood currently works at invoX Pharma Ltd., as Chief Executive Officer & Director from 2023, Karolinska Development AB, as Chairman from 2024, Pharmathen International SA, as Director & Vice President-Business Development from 2006, Softhale NV, as Director, PHion Therapeutics Ltd., as Director, and Sino Biopharmaceutical Ltd., as Head-Globalization from 2021.
Mr. Toogood also formerly worked at Sandoz AG, as Global Head-Business Development and Pharmathen SA, as Vice President-Business Development.
Mr. Toogood received his graduate degree from the University of the Witwatersrand, undergraduate degree from Rhodes University, and Masters Business Admin degree from the University of Cambridge.

Postes actifs de Benjamin Toogood

SociétésPosteDébut
KDVENTURES AB Président 18/12/2024
SINO BIOPHARMACEUTICAL LIMITED Corporate Officer/Principal 01/01/2021
Directeur/Membre du Conseil 01/01/2006
Directeur Général 08/03/2023
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -

Anciens postes connus de Benjamin Toogood

SociétésPosteFin
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Benjamin Toogood

Formation de Benjamin Toogood

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

54

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Commercial Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Benjamin Toogood
🔇